Sigma Planning Corp’s MacroGenics MGNX Stock Holding History

Sigma Planning Corp’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23,310	Closed	-$374K	–	1450
2021 Q4	$374K	Sell	23,310 -15	-0.1%	-$282	0.01%	975
2021 Q3	$488K	Sell	23,325 -875	-4%	-$21.1K	0.01%	829
2021 Q2	$650K	Buy	24,200 +14,650	+153%	+$429K	0.02%	726
2021 Q1	$304K	Buy	+9,550	New	+$232K	0.01%	987
2019 Q2	–	Sell	-10,600	Closed	-$191K	–	1029
2019 Q1	$191K	Buy	+10,600	New	+$183K	0.01%	859

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sigma Planning Corp's MGNX Position: Q1 2022 in Review

Sigma Planning Corp sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 23,310 shares — an estimated $374K sold.

Sigma Planning Corp first reported a position in MGNX in Q1 2019 and held it in 5 quarters. The position peaked at $650K in Q2 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

Sigma Planning Corp reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
Sigma Planning Corp sold 23,310 MacroGenics shares in Q1 2022, an estimated $374K.
Sigma Planning Corp first reported a position in MacroGenics in Q1 2019 and held it in 5 quarters.
Sigma Planning Corp's MacroGenics position peaked at $650K in Q2 2021.
144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Sigma Planning Corp's 13F filing for Q1 2022, filed 20 Apr 2022.